Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like PRA Health Sciences Announces The Center For Pediatric Clinical Development May 3, 2017 Sectra Signs Breast Imaging PACS Contract With August 23, 2017 Filings Reveal Billionaire Super-Investor Stocked Up on These 2 Biotech Stocks March 2, 2017